iStock_000007530244MediumRoche Holding AG has acquired CAPP Medical according to a press release via  “The acquisition will further strengthen Roche’s diagnostics portfolio. As per Roche, next-generation sequencing assays have the ability to significantly advance the duration of cancer diagnosis and change routine cancer diagnostic monitoring. This, in turn, can be highly cost effective compared to the current standard of using PET and CT imaging to monitor tumor progression.”  For more information, please visit: